UniCAP offers a long term treatment for middle-aged patients, who are not revised within the first 9  years

ConclusionsThere was a survival rate of approximately 40% after 9  years of follow-up, but in the group of patients (35–65 years old) not eligible for a final total arthroplasty. These patients were often left with pain and disability. This implant can be a temporary or even long-term treatment because it improved the disability and function over the long-term without a major progression in the osteoarthritis, function or pain. Long term results of this mini-prosthesis have not been previously reported.Level of evidenceIV.
Source: Knee Surgery, Sports Traumatology, Arthroscopy - Category: Orthopaedics Source Type: research